Literature DB >> 26713100

Supramolecular Inhibition of Neurodegeneration by a Synthetic Receptor.

Shengke Li1, Huanxian Chen1, Xue Yang1, David Bardelang2, Ian W Wyman3, Jianbo Wan1, Simon M Y Lee1, Ruibing Wang1.   

Abstract

Cucurbit[7]uril (CB[7]) was found in vitro to sequester the neurotoxins MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and MPP(+) (N-methyl-4-phenylpyridine). The CB[7]/neurotoxin host-guest complexes were studied in detail with (1)H NMR, electrospray ionization mass spectrometry, UV-visible spectroscopic titration, and molecular modeling by density functional theory. The results supported the macrocyclic encapsulation of MPTP and MPP(+), respectively, by CB[7] in aqueous solutions with relatively strong affinities and 1:1 host-guest binding stoichiometries in both cases. More importantly, the progression of MPTP/MPP(+) induced neurodegeneration (often referred to as a Parkinson's disease model) was observed to be strongly inhibited in vivo by the synthetic CB[7] receptor, as shown in zebrafish models. These results show that a supramolecular approach could lead to a new preventive and/or therapeutic strategy for counteracting the deleterious effects of some neurotoxins leading to neurodegeneration.

Entities:  

Keywords:  Neurodegeneration; cucurbituril; inhibition; neurotoxin; supramolecular complexation

Year:  2015        PMID: 26713100      PMCID: PMC4677361          DOI: 10.1021/acsmedchemlett.5b00372

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  31 in total

Review 1.  The MPTP model of Parkinson's disease.

Authors:  Richard Jay Smeyne; Vernice Jackson-Lewis
Journal:  Brain Res Mol Brain Res       Date:  2005-03-24

Review 2.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.

Authors:  Michael T Lin; M Flint Beal
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

3.  Controlling the biological effects of spermine using a synthetic receptor.

Authors:  Laurent Vial; R Frederick Ludlow; Julien Leclaire; Ruth Pérez-Fernandez; Sijbren Otto
Journal:  J Am Chem Soc       Date:  2006-08-09       Impact factor: 15.419

Review 4.  Parkinson's disease: insights from non-traditional model organisms.

Authors:  Ilse S Pienaar; Jürgen Götz; Mel B Feany
Journal:  Prog Neurobiol       Date:  2010-09-21       Impact factor: 11.685

Review 5.  Overview of tyrosine hydroxylase in Parkinson's disease.

Authors:  Yanzhen Zhu; Jing Zhang; Yanjun Zeng
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

6.  The ex vivo neurotoxic, myotoxic and cardiotoxic activity of cucurbituril-based macrocyclic drug delivery vehicles.

Authors:  Rabbab Oun; Rafael S Floriano; Lyle Isaacs; Edward G Rowan; Nial J Wheate
Journal:  Toxicol Res (Camb)       Date:  2014-11-01       Impact factor: 3.524

Review 7.  Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

Authors:  Dominic J Hare; Paul A Adlard; Philip A Doble; David I Finkelstein
Journal:  Metallomics       Date:  2013-02       Impact factor: 4.526

8.  MPTP and MPP+ target specific aminergic cell populations in larval zebrafish.

Authors:  V Sallinen; V Torkko; M Sundvik; I Reenilä; D Khrustalyov; J Kaslin; P Panula
Journal:  J Neurochem       Date:  2008-11-27       Impact factor: 5.372

9.  Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.

Authors:  B Giros; S el Mestikawy; N Godinot; K Zheng; H Han; T Yang-Feng; M G Caron
Journal:  Mol Pharmacol       Date:  1992-09       Impact factor: 4.436

10.  Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.

Authors:  H Kinemuchi; Y Arai; Y Toyoshima
Journal:  Neurosci Lett       Date:  1985-07-31       Impact factor: 3.046

View more
  6 in total

1.  Acyclic Cucurbit[n]uril-Type Molecular Containers: Influence of Linker Length on Their Function as Solubilizing Agents.

Authors:  David Sigwalt; Damien Moncelet; Shane Falcinelli; Vijaybabu Mandadapu; Peter Y Zavalij; Anthony Day; Volker Briken; Lyle Isaacs
Journal:  ChemMedChem       Date:  2016-03-15       Impact factor: 3.466

Review 2.  Supramolecular hosts as in vivo sequestration agents for pharmaceuticals and toxins.

Authors:  Chun-Lin Deng; Steven L Murkli; Lyle D Isaacs
Journal:  Chem Soc Rev       Date:  2020-10-12       Impact factor: 54.564

3.  Cucurbit[7]uril as a Broad-Spectrum Antiviral Agent against Diverse RNA Viruses.

Authors:  Jia Quan; Xiangjun Zhang; Yuanfu Ding; Shengke Li; Yang Qiu; Ruibing Wang; Xi Zhou
Journal:  Virol Sin       Date:  2021-05-26       Impact factor: 6.947

Review 4.  Recent advances in supramolecular antidotes.

Authors:  Hang Yin; Xiangjun Zhang; Jianwen Wei; Siyu Lu; David Bardelang; Ruibing Wang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

5.  A combined crystallography and DFT study on ring-shaped Cucurbit[n]urils: structures, surface character, and host-guest recognition.

Authors:  Guoxun Zhu; Ao You; Huacan Song; Zhengquan Li
Journal:  RSC Adv       Date:  2022-03-30       Impact factor: 3.361

6.  In Vitro selectivity of an acyclic cucurbit[n]uril molecular container towards neuromuscular blocking agents relative to commonly used drugs.

Authors:  Shweta Ganapati; Peter Y Zavalij; Matthias Eikermann; Lyle Isaacs
Journal:  Org Biomol Chem       Date:  2015-12-09       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.